At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 12 enrolled
Drug / intervention
FMX101 vehicle +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Evaluator-Blinded, Bilateral Comparison Study of Two Topicals in the Treatment of Subjects With Acne Vulgaris
In Brief
A Phase 1 clinical trial evaluating FMX101 vehicle and Hydro-alcohol solution for Acne Vulgaris. Completed, enrolled 12 participants across 1 site.
Detailed Summary
A Randomized, Evaluator-Blinded, Bilateral Comparison Study to Evaluate the Safety and Efficacy of Two Topicals in the Treatment of Subjects With Acne Vulgaris (Study FX2018-23).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20192020202120222023202420252026
First PostedNov 2018
Enrollment StartNov 2018
Primary CompletionFeb 2019
TodayJul 2026
First PostedNov 15, 2018
Enrollment StartNov 20, 2018
Primary CompletionFeb 11, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.6 years ago
Interventions
FMX101 vehicledrug
FMX101 vehicle - hydrophobic oil based vehicle (Test Article A)
Hydro-alcohol solutionother
Hydro-alcohol solution based vehicle (Test Article B)